Results 81 to 90 of about 2,848,507 (217)
Experimental Physiology, EarlyView.Abstract Chronic kidney disease–mineral and bone disorder (CKD‐MBD) is a major complication of chronic kidney disease (CKD), characterized by disruptions in mineral metabolism, abnormal bone turnover and vascular calcification, which collectively increase the risk of fractures and cardiovascular disease.
Alief Waitupu +4 more
wiley +1 more source
Multiple brown tumors in a patient with nutritional secondary hyperparathyroidism.
, 1989 For years, brown tumors have been considered to be a characteristic of primary hyperparathyroidism. However, since 1963 several reports indicate that the incidence of brown tumors in patients with renal secondary hyperparathyroidism to be 1.5%-1.7%.
Mergenthaler, H.G. +4 more
core +1 more source
Gait and Plantar Pressure Analysis in Charcot Neuroarthropathy: A Clinic‐Based Biomechanical Study
Journal of Foot and Ankle Research, Volume 19, Issue 4, December 2026.ABSTRACT Introduction Charcot Neuroarthropathy (CN) is a progressive joint disorder resulting from peripheral neuropathy and repetitive microtrauma. Management prioritizes offloading to prevent deformity, ulceration, infection, and amputation. While three‐dimensional gait analysis can be useful for disease staging and guiding management, its cost and ...
Irene M. Laleye +8 more
wiley +1 more source
, 2018 Takashi Shigematsu,1 Ryutaro Shimazaki,2 Masafumi Fukagawa,3 Tadao Akizawa4 On behalf of the Evocalcet Study Group 1Department of Nephrology, Wakayama Medical University, Wakayama, Japan; 2R&D Division, Kyowa Hakko Kirin Co., Ltd., Chiyoda-ku, Tokyo,
Shigematsu T +3 more
core
Eurasian Journal of Medicine, 2019 Parathyroid hormone (PTH) has been shown to enhance erythrocyte osmotic fragility and has been incriminated as a factor in the anemia seen in patients with chronic renal failure and secondary hyperparathyroidism.
Celalettin Koşan, Lale Sever
doaj
Basic &Clinical Pharmacology &Toxicology, Volume 139, Issue 6, December 2026.ABSTRACT We previously developed nanobodies acting as positive allosteric modulators (PAMs) of the calcium‐sensing receptor (CaSR). Here, we sought to develop more potent CaSR modulators by creating bivalent nanobody constructs using ‘tail‐to‐head’ peptide‐linker conjugation.
Mahdis Nabipour +5 more
wiley +1 more source
Suspected hyperthyroidism‐associated myoclonus in a cat
Veterinary Record Case Reports, Volume 14, Issue 4, November 2026.Abstract A 10‐year‐old, male, neutered domestic shorthair cat presented with a 2‐week history of progressively worsening myoclonic jerks predominantly involving the head. Jerks were continuous and marked at rest, but became less intense during activity.
Magdalena Maria Dyrka +5 more
wiley +1 more source
Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide
, 2017 Mario Cozzolino,1 Andrea Galassi,1 Ferruccio Conte,1 Michela Mangano,1 Luca Di Lullo,2 Antonio Bellasi1,3 1Department of Health Sciences, Renal Division, University of Milan, ASST Santi Paolo e Carlo, San Paolo Hospital, Milan, 2U.O.C.
Mangano M +5 more
core
Mandibular Osteitis Fibrosa Cystica as First Sign of Vitamin D Deficiency
Case Reports in Dentistry, 2018 Introduction. Brown tumors of hyperparathyroidism are locally destructive bone lesions. They are the late clinical consequence of the disease. They can occur in primary, secondary, and rarely tertiary forms.
Nour Mellouli +5 more
doaj +1 more source
Veterinary Record Case Reports, Volume 14, Issue 4, November 2026.Abstract A 5‐year‐old, spayed, female Shiba Inu was presented with a 6‐week history of reduced appetite, lethargy and generalised stiffness, which showed only limited improvement despite anti‐inflammatory treatment. The most significant clinical abnormalities were pyrexia, stiffness, pain on joint manipulation and cutaneous lesions. Laboratory findings
Jeanne Bergeat +6 more
wiley +1 more source